Format

Send to

Choose Destination
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2):81-84. doi: 10.17116/jnevro20171172181-84.

[A dyad approach to the treatment of attention deficit hyperactivity disorder].

[Article in Russian; Abstract available in Russian from the publisher]

Author information

1
N. Bekhtereva Human Brain Research Institute, Russian Academy of Science, St. Petersburg, Russia.

Abstract

in English, Russian

AIM:

To study anxiety in adolescents with attention deficit hyperactivity disorder (ADHD) and their mothers and to evaluate the efficacy of a dyad approach (simultaneous treatment of the mother and the child) to ADHD treatment.

MATERIAL AND METHODS:

Thirty-four adolescents, aged 12-15 years, with ADHD and their mothers were studied. All participants of the study received anxiolytic treatment: children were treated with noophen (500 mg per day 45 days) and their mothers received adaptol (1500 mg per day 45 days). In the comparison group with the same clinical/psychological characteristics, anxiolytic therapy with noophen was used only in adolescents.

RESULTS:

Symptoms of anxiety were found in 61.7% of adolescents with ADHD and in 79.4% of the mothers. After the dyad therapy, an improvement was noted in 73.5% of adolescents and 69.7% of the mothers. There was an improvement in 63.3% of patients in the comparison group.

CONCLUSION:

The results demonstrate the high efficacy of the dyad approach in treatment of ADHD with comorbid anxiety disorders.

PMID:
28374698
DOI:
10.17116/jnevro20171172181-84
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center